How About Establishing a Caregiver Protocol? 1:04
FDA Warns About Severe MS Worsening After Stopping Gilenya 4:54
Phase 2 Clinical Trial Planned for NurOwn Cell Therapy for Treating Progressive MS 6:30
ATA190 Cell Therapy Shows Promising Phase 1 Clinical Trial Results for Treating Progressive MS 7:43
MS Society's MS Navigator Program Demonstrates Its Impressive Reach & Effectiveness 10:36
Scott Williams, Vice-President, Head of Global Patient Advocacy and Strategic Partnerships, Discusses EMD Serono's Commitment to MS Caregivers 14:08
___________
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes
in the RealTalk MS app or at www.RealTalkMS.com
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
FDA Warns About Severe Worsening of Multiple Sclerosis After Stopping the Medicine Gilenya
Epstein-Barr Virus-Specific T Cell Therapy for Progressive Multiple Sclerosis
RealTalk MS Episode 19: MS Navigators — A Seriously Remarkable Service That You Need to Know About
DOCUMENTARY: Seeing MS From the Inside Out
Give RealTalk MS a Rating & Review
___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 66
Hosted By: Jon Strum
Guest: Scott Williams
Tags: MS, MultipleSclerosis, MSsociety, Gilenya, ProgressiveMS, MSInsideOut, EmbracingCarers, Caregiving, RealTalkMS